Late effects in survivors of infant leukemia

Leukemia

Volumn 14, Issue 7, 2000, Pages 1185-1190

  Leung, W ^a   Hudson, M ^a   Zhu, Y ^a   Rivera, G K ^a   Ribeiro, R C ^a   Sandlund, J T ^a   Bowman, L C ^a   Evans, W E ^a,b   Kun, L ^a,b   Pui, C H ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Infant ALL; Infant AML; Infant leukemia; Late effects

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BODY HEIGHT; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CATARACT; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; FEMALE; FOLLOW UP; GROWTH DISORDER; HEARING DISORDER; HEART DISEASE; HUMAN; HYPOTHYROIDISM; INFANT DISEASE; LEARNING DISORDER; MALE; PRIORITY JOURNAL;

EID: 12944281810     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401818     Document Type: Article

References (38)

1. Pui CH. Childhood leukemia. New Engl J Med 1995; 332: 1618-1630.
2. Pui CH, Kane JR, Crist WM. Biology and treatment of infant leukemia. Leukemia 1995; 9: 762-769.
3. Felix CA, Lange BJ. Leukemia in infants. Oncologist 1999; 4: 225-240.
4. Pui CH, Ribeiro RC, Campana D, Raimondi SC, Hancock ML, Behm FG, Sandlund JT, Rivera GK, Evans WE, Crist WM, Krance R. Prognostic factors in the acute lymphoid and myeloid leukemia of infants. Leukemia 1996; 10: 952-956.
5. Pui CH, Behm FG, Downing JR, Hancock ML, Shurtleff SA, Ribeiro RC, Head DR, Mahmoud HH, Sandlund JT, Furman WL, Roberts WM, Crist WM, Raimondi SC. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol 1994; 12: 909-915.
6. Reaman GH, Sposto R, Sensel MG, Lange BJ, Feusner JH, Heerenia NA, Leonard M, Holmes EJ, Sather HN, Pendergrass TW, Johnstone HS, O'Brien RT, Steinherz PG, Zeltzer PM, Gaynon PS, Trigg ME, Uckun FM. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. J Clin Oncol 1999; 17: 445-455.
7. Dordelmann M, Reiter A, Borkhardt A, Ludwig WD, Gotz N, Viehmann S, Gadner H, Riehm H, Schrappe M. Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood 1999; 94: 1209-1217.
8. Pui CH, Raimondi SC, Srivastava DK, Tong X, Behm FG, Razzouk B, Rubnitz JE, Sandlund JT, Evans WE, Ribeiro R. Prognostic factors in infants with acute myeloid leukemia. Leukemia 2000; 14: 684-687.
9. McLeod HL, Relling MV, Crom WR, Silverstein K, Groom S, Rodman JH, Rivera GK, Crist WM, Evans WE. Disposition of antineoplastic agents in the very young child. Br J Cancer 1992; 66 (Suppl. 18): S23-29.
10. Pui CH, Kalwinsky DK, Schell MJ, Mason CA, Mirro J Jr, Dahl GV. Acute nonlymphoblaslic leukemia in infants: clinical presentation and outcome. J Clin Oncol 1988; 6: 1008-1013.
11. Aur RJ, Hustu HO, Verzosa MS, Wood A, Simone JV. Comparison of two methods of preventing central nervous system leukemia. Blood 1973; 42: 349-357.
12. Aur RJ, Simone JV, Verzosa MS, Hustu HO, Barker LF, Pinkel DP, Rivera G, Dahl GV, Wood A, Stagner S, Mason C. Childhood acute lymphocytic leukemia: study VIII. Cancer 1978; 42: 2123-2134.
13. Pui CH, Aur RJ, Bowman WP, Dahl GV, Dodge RK, George SL, Ochs J, Kalwinsky DK, Abromowitch M, Hustu HO. Failure of late intensification therapy to improve a poor result in childhood lymphoblastic leukemia. Cancer Res 1984; 44: 3593-3548.
14. Pui CH, Simone IV, Hancock ML, Evans WE, Williams DL, Bowman WP, Dahl GV, Dodge RK, Ochs J, Abromowitch M, Rivera GK. Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of St Jude total therapy study X. Leukemia 1992; 6: 150-157.
15. Rivera GK, Raimondi SC, Hancock ML, Behm FG, Pui CH, Abromowitch M, Mirro J Jr, Ochs IS, Look AT, Williams DL. Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet 1991; 337: 61-66.
16. Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. New Engl J Med 1998; 338: 499-505.
17. Pui CH, Mahmoud HH, Rivera GK, Hancock ML, Sandlund JT, Behm FG, Head DR, Relling MV, Ribeiro RC, Rubnitz JE, Kun LE, Evans WE. Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood 1998; 92: 411-415.
18. Ribeiro RC, Rivera CK, Hudson M, Mulhern RK, Hancock ML, Kun L, Mahmoud H, Sandlund JT, Crist WM, Pui CH. An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia. J Clin Oncol 1995; 13: 333-338.
19. Relling MV, Mahmoud HH, Pui CH, Sandlund JT, Rivera GK, Ribeiro RC, Crist WM, Evans WE. Etoposide achieves potentially cytotoxic concentrations in CSF of children with acute lymphoblastic leukemia. J Clin Oncol 1996, 14: 399-104.
20. Dahl CV, Kalwinsky DK, Murphy S, Look AT, Amadori S, Kumar M, Novak R, George SL, Mason C, Mauer AM, Simone JV. Cytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia. Blood 1982; 60: 856-863.
21. Dahl GV, Kalwinsky DK, Mirro J Jr, Look AT, Pui CH, Murphy SB, Mason C, Ruggiero M, Schell M, Johnson FL, Thomas ED. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission. J Clin Oncol 1990; 8: 295-303.
22. Kalwinsky O, Mirro J Jr, Schell M, Behm F, Mason C, Dahl GV. Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: improved remission induction with a five-drug regimen including etoposide. J Clin Oncol 1988; 6: 1134-1143.
23. Hurwitz CA, Krance R, Schell MJ, Santana VM, Brenner MK, Ribeirio R, Roberts WM, Mahmoud H, Belt J, Crom W. Current strategies for treatment of acute myeloid leukemia at St Jude Children's Research Hospital. Leukemia 1992; 6 (Suppl. 2): 39-43.
24. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291-303.
25. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970; 45: 13-23.
26. Tanner JM, Davies PS. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr 1985; 107: 317-329.
27. Mulhern RK, Kovnar E, Langston J, Carter M. Fairclough D, Leigh L, Kun LE. Long-term survivors of leukemia treated in infancy: factors associated with neuropsychologic status. J Clin Oncol 1992; 10: 1095-1102.
28. Mulhern RK, Fairclough D, Ochs J. A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation. J Clin Oncol 1991; 9: 1348-1356.
29. Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 1952; 47: 583-621.
30. Mehta CR, Patel NR. A network algorithm for performing Fisher's exact test in r x c contingency tables. J Am Stat Assoc 1983; 78: 427-434.
31. Tritchler D. An algorithm for exact logistic regression. J Am Stat Assoc 1984; 79: 709-711.
32. Schell MJ, Ochs JJ, Schriock EA, Carter M. A method of predicting adult height and obesity in long-term survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 1992; 10: 128-133.
33. Craig F, Leiper AD, Stanhope R, Brain C, Meller ST, Nussey SS. Sexually dimorphic and radiation dose dependent effect of cranial irradiation on body mass index. Arch Dis Child 1999; 81: 500-504.
34. Reaman G, Zeltzer P, Bleyer W, Amendola B, Level C, Sather H, Hammond D. Acute lymphoblastic leukemia in infants less than one year of age: a cumulative experience of the Children's Cancer Study Group. J Clin Oncol 1985; 3: 1513-1521.
35. Silverman LB, McLean TW, Gelber RD, Donnelly MJ, Gilliland DG, Tarbell NJ, Sallan SE. Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium. Cancer 1997; 80: 2285-2295.
36. Ferster A, Bertrand Y, Benoit Y, Boilletot A, Behar C, Margueritte G, Thyss A, Robert A, Mazingue F, Souillet G. Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC-Childhood Leukaemia Cooperative Group. Br J Haematol 1994; 86: 284-290.
37. Waber DP, Tarbell NJ, Fairclough D, Atmore K, Castro R, Isquith P, Lusher F, Romero I, Carpenter PJ, Schiller M. Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice. J Clin Oncol 1995; 13: 2490-2496.
38. Kaleita TA, Reaman GH, MacLean WE, Sather HN, Whitt JK. Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report. Cancer 1999; 85: 1859-1865.